These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3044983)

  • 21. [Use of synthetic carriers and adjuvants for increasing the immunogenicity of a synthetic peptide from the CS-protein of Plasmodium falciparum].
    Ivanov BB; Meshcheriakova EA; Andronova TM; Ivanov VT
    Bioorg Khim; 1991 Jun; 17(6):732-46. PubMed ID: 1723268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody responses to Plasmodium falciparum and P. vivax sporozoites in areas with stable and unstable malaria.
    Del Giudice G; Lambert PH; Mendis K; Pessi A; Tanner M
    Bull World Health Organ; 1990; 68 Suppl(Suppl):191-6. PubMed ID: 2094587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacy.
    Jakobsen H; Hannesdottir S; Bjarnarson SP; Schulz D; Trannoy E; Siegrist CA; Jonsdottir I
    Eur J Immunol; 2006 Feb; 36(2):287-95. PubMed ID: 16385627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Models for assessing the effect of toxicants on immunocompetence in mice. II. Effect of cyclophosphamide on the antibody responses to type III pneumococcal polysaccharide and tetanus toxoid in BALB/c female mice.
    Speirs RS; Benson RW; Knowles BJ; Roberts D
    J Environ Pathol Toxicol; 1978; 1(6):791-812. PubMed ID: 32218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
    Wang R; Charoenvit Y; Corradin G; Porrozzi R; Hunter RL; Glenn G; Alving CR; Church P; Hoffman SL
    J Immunol; 1995 Mar; 154(6):2784-93. PubMed ID: 7876549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of 5.1-[NANP]19, a recombinant Plasmodium falciparum vaccine candidate, in adults.
    Stürchler D; Just M; Berger R; Reber-Liske R; Matile H; Etlinger H; Takacs B; Rudin C; Fernex M
    Trop Geogr Med; 1992 Jan; 44(1-2):9-14. PubMed ID: 1496731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
    Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G
    Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.
    Bergmann ES; Ballou RW; Krzych U
    Cell Immunol; 1997 Sep; 180(2):143-52. PubMed ID: 9341744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human IL-2 overcomes genetic nonresponsiveness to malaria sporozoite peptides. Correlation of effect with biologic activity of IL-2.
    Good MF; Pombo D; Lunde MN; Maloy WL; Halenbeck R; Koths K; Miller LH; Berzofsky JA
    J Immunol; 1988 Aug; 141(3):972-7. PubMed ID: 2969396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials.
    Nardin E; Zavala F; Nussenzweig V; Nussenzweig RS
    Parassitologia; 1999 Sep; 41(1-3):397-402. PubMed ID: 10697892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycobacterial heat-shock proteins as carrier molecules.
    Lussow AR; Barrios C; van Embden J; Van der Zee R; Verdini AS; Pessi A; Louis JA; Lambert PH; Del Giudice G
    Eur J Immunol; 1991 Oct; 21(10):2297-302. PubMed ID: 1680693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of protective immunity against experimental infection with malaria using synthetic peptides.
    Patarroyo ME; Romero P; Torres ML; Clavijo P; Moreno A; Martínez A; Rodríguez R; Guzman F; Cabezas E
    Nature; 1987 Aug 13-19; 328(6131):629-32. PubMed ID: 3302727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design.
    Amante FH; Crewther PE; Anders RF; Good MF
    J Immunol; 1997 Dec; 159(11):5535-44. PubMed ID: 9548494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier.
    Lise LD; Mazier D; Jolivet M; Audibert F; Chedid L; Schlesinger D
    Infect Immun; 1987 Nov; 55(11):2658-61. PubMed ID: 2444539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative analysis of ELISAs employing repetitive peptides to detect antibodies to Plasmodium falciparum sporozoites.
    Del Giudice G; Douglas A; Verhave JP; Wirtz RA; Zavala F
    Bull World Health Organ; 1989; 67(5):515-23. PubMed ID: 2692868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antibody response in BALB/c mice to the Plasmodium falciparum circumsporozoite repetitive epitope covalently coupled to synthetic lipopeptide adjuvant.
    Wiesmüller KH; Jung G; Gillessen D; Loffl C; Bessler WG; Böltz T
    Immunology; 1991 Jan; 72(1):109-13. PubMed ID: 1705236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of a non-repetitive sequence of Plasmodium falciparum circumsporozoite protein in man and mice.
    Del Giudice G; Cheng Q; Mazier D; Berbiguier N; Cooper JA; Engers HD; Chizzolini C; Verdini AS; Bonelli F; Pessi A
    Immunology; 1988 Feb; 63(2):187-91. PubMed ID: 2450833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of interferons on immune response to a synthetic peptide malaria sporozoite vaccine in non-immune adults.
    Stürchler D; Berger R; Etlinger H; Fernex M; Matile H; Pink R; Schlumbom V; Just M
    Vaccine; 1989 Oct; 7(5):457-61. PubMed ID: 2479187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of a tuberculin purified protein derivative--Asn-Ala-Asn-Pro conjugate in bacillus Calmette-Guérin primed mice overcomes H-2 restriction of the antibody response and avoids the need for adjuvants.
    Lussow AR; Del Giudice G; Rénia L; Mazier D; Verhave JP; Verdini AS; Pessi A; Louis JA; Lambert PH
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):2960-4. PubMed ID: 2183219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.